PAVmed Statistics
Total Valuation
PAVmed has a market cap or net worth of $13.68 million. The enterprise value is $37.83 million.
| Market Cap | 13.68M |
| Enterprise Value | 37.83M |
Important Dates
The last earnings date was Monday, May 13, 2024, after market close.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PAVmed has 9.43 million shares outstanding. The number of shares has increased by 34.33% in one year.
| Shares Outstanding | 9.43M |
| Shares Change (YoY) | +34.33% |
| Shares Change (QoQ) | +8.38% |
| Owned by Insiders (%) | 6.28% |
| Owned by Institutions (%) | 14.17% |
| Float | 8.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.53 |
| Forward PS | 2.80 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.54
| Current Ratio | 0.54 |
| Quick Ratio | 0.47 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -144.63 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -171.10% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $28,187 |
| Profits Per Employee | -$664,047 |
| Employee Count | 107 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.90% in the last 52 weeks. The beta is 0.83, so PAVmed's price volatility has been lower than the market average.
| Beta (1Y) | 0.83 |
| 52-Week Price Change | -75.90% |
| 50-Day Moving Average | 1.98 |
| 200-Day Moving Average | 3.20 |
| Relative Strength Index (RSI) | 35.53 |
| Average Volume (30 Days) | 57,933 |
Short Selling Information
The latest short interest is 379,359, so 4.02% of the outstanding shares have been sold short.
| Short Interest | 379,359 |
| Short Previous Month | 435,397 |
| Short % of Shares Out | 4.02% |
| Short % of Float | 4.42% |
| Short Ratio (days to cover) | 6.67 |
Income Statement
In the last 12 months, PAVmed had revenue of $3.02 million and -$71.05 million in losses. Loss per share was -$9.08.
| Revenue | 3.02M |
| Gross Profit | -3.80M |
| Operating Income | -62.43M |
| Pretax Income | -61.46M |
| Net Income | -71.05M |
| EBITDA | -58.01M |
| EBIT | -61.03M |
| Loss Per Share | -$9.08 |
Balance Sheet
The company has $25.54 million in cash and $49.69 million in debt, giving a net cash position of -$24.15 million or -$2.56 per share.
| Cash & Cash Equivalents | 25.54M |
| Total Debt | 49.69M |
| Net Cash | -24.15M |
| Net Cash Per Share | -$2.56 |
| Equity / Book Value | -68.78M |
| Book Value Per Share | -7.29 |
| Working Capital | -25.44M |
Cash Flow
In the last 12 months, operating cash flow was -$48.86 million and capital expenditures -$258,000, giving a free cash flow of -$49.12 million.
| Operating Cash Flow | -48.86M |
| Capital Expenditures | -258,000 |
| Free Cash Flow | -49.12M |
| FCF Per Share | -$5.65 |
Margins
Gross margin is -126.09%, with operating and profit margins of -2,069.99% and -2,355.87%.
| Gross Margin | -126.09% |
| Operating Margin | -2,069.99% |
| Pretax Margin | -2,037.67% |
| Profit Margin | -2,355.87% |
| EBITDA Margin | -1,923.47% |
| EBIT Margin | -2,023.67% |
| FCF Margin | -1,628.51% |
Dividends & Yields
PAVmed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.33% |
| Shareholder Yield | -34.33% |
| Earnings Yield | -519.55% |
| FCF Yield | -359.14% |
Analyst Forecast
The average price target for PAVmed is $8.61, which is 493.79% higher than the current price. The consensus rating is "Hold".
| Price Target | $8.61 |
| Price Target Difference | 493.79% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 150.81% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 7, 2023. It was a reverse split with a ratio of 1:15.
| Last Split Date | Dec 7, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
PAVmed has an Altman Z-Score of -17.64 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -17.64 |
| Piotroski F-Score | 4 |